DevelRx are pleased to announce a joint podcast with the CRO, Altasciences, 'The Next Trip – Developing the Second Generation of Psychedelics and their Analogs for Targeted Medical Use'.
In this podcast, which will air on Tuesday 21st September 2021, 10.30 -11.30 am ET, 3.30 - 4.30 pm BST, experts from DevelRx and Altasciences will examine the preclinical, clinical and regulatory challenges facing the development of more efficacious and safer psychedelic drugs.
Speakers from DevelRx are: David Heal (Executive Director) and Chris Atterwill (Consultant). Participants from Altasciences are: Beatrice Setnik (CSO), Debra Kelsh (Principal Investigator, Phase I Clinical Development) and Denise Milovan (Neuroscientist, Clinical Neuropsychologist).
DevelRx have worked on psychedelic drugs for many years. Please get in touch to learn more about our expertise in this area and to find out how we can facilitate the development of your novel psychedelic drugs.